Skip to main content

Day: September 29, 2021

Evoke Pharma’s Commercial Partner EVERSANA, Receives PM360’s Trailblazer Initiative Award for Innovation in Healthcare Marketing for GIMOTI

Award for “Spray Away” Campaign seeking to drive patient and provider awareness for the novel nasal spray treatment of symptoms of Diabetic Gastroparesis SOLANA BEACH, Calif., Sept. 29, 2021 (GLOBE NEWSWIRE) — Evoke Pharma® (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, and EVERSANA™, a leading provider of global commercial services to the life sciences industry, today announced that PM360, a publication for marketing decision makers in the pharmaceutical, biotech, and medical device industries named both companies as the Sales Aid Silver Award Winner for GIMOTI® under the Trailblazer Initiative Awards during PM360’s annual awards ceremony on September 23, 2021. Received as a result of the “Spray Away Campaign” developed by Evoke Pharma and EVERSANA ENGAGE, the Sales...

Continue reading

Quorum Announces Lead Generator is General Motors (GM) Certified

Quorum to sell both Lead Generator and Autovance Desk as GM REP certified products CALGARY, Alberta, Sept. 29, 2021 (GLOBE NEWSWIRE) — Quorum Information Technologies Inc. (TSX Venture: QIS) (Quorum) is pleased to announce that its Lead Generator software has been named a certified product under the GM Retail Excellence Program (REP) by General Motors of Canada. Lead Generator is a comprehensive tool that utilizes key analytics to allow dealerships to find customers that may be in the market for their next vehicle, including customers that have a positive equity position in their trade-in vehicle. “Lead Generator helps us anticipate a customer’s needs and find customers that may be in the market for a new vehicle,” stated Glenn Smaha, General Manager of Davis Chevrolet GMC Buick in Airdrie, AB. “Additionally, like all products...

Continue reading

Theratechnologies to Announce Financial Results for Its Third Quarter Fiscal 2021

MONTREAL, Sept. 29, 2021 (GLOBE NEWSWIRE) — Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) (Theratechnologies), a biopharmaceutical company focused on the development and commercialization of innovative therapies, announced today that it will report financial results for its third quarter of fiscal 2021 ended August 31, 2021 on Wednesday, October 13, 2021. A conference call will be held on October 13, 2021 at 8:30 a.m. (ET) to discuss the results and recent business updates. The call will be hosted by Paul Lévesque, President and Chief Executive Officer. Mr. Lévesque and other members of the management team will be available to answer questions from participants following prepared remarks. The conference call can be accessed by dialing 1-844-400-1697 (toll free) or 1-703-736-7400 (International). The conference call will also...

Continue reading

Churchill Downs Incorporated Signs Agreement with Chicago Bears for Arlington Heights Property

LOUISVILLE, Ky., Sept. 29, 2021 (GLOBE NEWSWIRE) — Churchill Downs Incorporated (“CDI” or “Company”) (Nasdaq: CHDN) announced today that the Company has signed a Purchase and Sale Agreement with the Chicago Bears. The Company has agreed to sell the 326-acre property in Arlington Heights, Illinois, (“the Property”) currently the home of Arlington International Racecourse, for $197.2 million. The closing of the sale of the Property is subject to the satisfaction of various closing conditions. The Company anticipates closing the sale of the Property in late 2022 / early 2023. CDI is planning to use the proceeds of the sale to purchase or invest in replacement property that qualifies as an Internal Revenue Code §1031 transaction. About Churchill Downs Incorporated Churchill Downs Incorporated is an industry-leading racing, online wagering...

Continue reading

SCYNEXIS Presents Interim Analysis from FURI at Virtual IDWeek 2021 Showing Favorable Therapeutic Response in Severe Hospital-Based Fungal Infections Treated with Oral Ibrexafungerp

Subpopulation analysis of 74 patients from ongoing Phase 3 FURI study demonstrated similar efficacy against multiple serious fungal infections JERSEY CITY, N.J., Sept. 29, 2021 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced an oral presentation of analyses of interim data from its ongoing Phase 3 FURI study showing favorable clinical activity of oral ibrexafungerp in severe hospital-based fungal infections across multiple serious fungal infections. The compilation and disease subset analyses are being presented during IDWeek, taking place virtually September 29 – October 3, 2021. “We are very pleased to share the results of these analyses to help provide greater understanding of ibrexafungerp...

Continue reading

Nemaura Medical Launches Beta Version of Its Metabolic Health Program

MiBoKo, a noninvasive glucose sensor utilizing AI mobile application, addresses a substantial multibillion-dollar market opportunity in healthcare LOUGHBOROUGH, England, Sept. 29, 2021 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or “the Company”), a medical technology company focused on developing and commercializing noninvasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, announces the beta launch of MiBoKo, a new metabolic health program utilizing a noninvasive glucose sensor along with an AI mobile application. Dr. Faz Chowdhury, Nemaura’s Chief Executive Officer, will discuss MiBoKo in more detail during his corporate presentation scheduled for today, September 29, 2021 at 11:10 a.m. ET during the Benzinga Healthcare Small Cap Conference. Investors can access this...

Continue reading

Transcontinental Inc. Announces the Renewal of Its Normal Course Issuer Bid Plan

MONTRÉAL, Sept. 29, 2021 (GLOBE NEWSWIRE) — Transcontinental Inc. (TSX: TCL.A TCL.B) has been authorized to purchase for cancellation on the open market, between October 1st, 2021 and September 30, 2022, up to 1,000,000 of its Class A Subordinate Voting Shares and up to 190,300 of its Class B Shares, representing approximately 1.37% of the 73,111,944 issued and outstanding Class A Subordinate Voting Shares and of the 13,913,226 issued and outstanding Class B Shares as of September 17, 2021. The average daily trading volume on the Toronto Stock Exchange of Class A Subordinate Voting Shares for the past six months was 175,745 and the average daily trading volume on the Toronto Stock Exchange of Class B Shares for the past six months was 392. In accordance with the Toronto Stock Exchange requirements, a maximum daily purchase of the...

Continue reading

Loop Media Studios Launches First Audio Original With “Asia Pop40” Podcast

AVAILABLE NOW ON SPOTIFY, THE SHOW EXPANDS THE REACH OF LOOP MEDIA’S INTERNATIONALLY SYNDICATED WEEKLY RADIO PROGRAM Glendale, CA, Sept. 29, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Loop Media Studios, a division of Loop Media, Inc. (“Loop Media” or the “Company”) (OTC: LPTV), a leading multichannel streaming platform that provides curated music videos and branded entertainment channels for businesses and consumers, announced today the launch of the Company’s first audio-only offering, the “Asia Pop40” podcast. Loop Media Studios is Loop Media’s division responsible for content creation, curation and distribution.   The Asia Pop40 podcast reaches audiences worldwide on Spotify and features the top 10 songs each week in Asia that appear on Loop Media’s syndicated Asia Pop40 radio program, which is aired in more than...

Continue reading

Reliq Health Technologies, Inc. to Present at Lytham Partners Fall 2021 Investor Conference

HAMILTON, Ontario, Sept. 29, 2021 (GLOBE NEWSWIRE) — Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global telemedicine company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, is pleased to announce that it will participate in the Lytham Partners Fall 2021 Investor Conference from October 5-7. Reliq’s CEO, Dr. Lisa Crossley, will deliver the company’s latest investor presentation and engage in a fireside chat session on Tuesday, October 5, 2021 at 1:15pm ET. “We look forward to sharing the most recent updates on our rapidly growing business with investors at this year’s Lytham Partners Fall 2021 Investor Conference,” said Dr. Lisa Crossley, CEO at Reliq Health. A webcast of the presentation will be available on the...

Continue reading

Newtek Business Services Corp.’s Board of Directors’ Elects Two New Board Members

BOCA RATON, Fla., Sept. 29, 2021 (GLOBE NEWSWIRE) — Newtek Business Services Corp. (the “Company”) (Nasdaq: NEWT), an internally managed business development company (“BDC”), today announced that its board of directors (the “Board”) has elected two new directors to the Board, Fernando Perez-Hickman and Halli Razon-Feingold, increasing the Board to seven (7) directors. The Board will now be comprised of four (4) independent directors and three (3) interested directors, as such term is defined under Section 2(a)(19) of the Investment Company Act of 1940 (the “1940 Act”). Mr. Perez-Hickman is an experienced executive with a proven track record in management, mergers & acquisitions, and value creation at financial services businesses. Mr. Perez-Hickman previously served as Vice Chairman, Director of Corporate Strategy and member...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.